Credit: 7activestudio/ Getty Images With almost 20 already approved since 2000, including some blockbusters, antibody drug conjugates (ADCs) are clearly…
Synaffix, a Lonza company focused on commercializing its clinical-stage platform technology for the development of antibody-drug conjugates (ADCs), entered into…
